EBSCOhost
ebsco.com

Newsletter Archives

Showing 121 to 140 of 904 articles.

EBM Focus - Volume 17, Issue 28

Race-Specific Criteria for PFTs Contribute to Health Disparities

MBE em Foco - Volume 8, Issue 14

Medicina de Precisão ou Medicina de Pretensão? Notícias deprimentes para os testes genômicos

EBM Focus - Volume 17, Issue 27

Precision Medicine or Pretending? Depressing News for Genomic Testing

EBM Focus - Volume 17, Issue 26

Please Take the Sunshine Away: Vitamin D Still Doesn’t Work for Primary Fracture Prevention

MBE em Foco - Volume 8, Issue 13

Jejum intermitente: hackeamento metabólico ou truque mental para a perda de peso?

MBE em Foco - Volume 8, Issue 12

Sobrevivendo ao excesso de diagnósticos no câncer de mama

MBE em Foco - Volume 8, Issue 11

Estamos encurtando a COVID longa com as vacinas?

EBM Focus - Volume 17, Issue 25

Should Rescue Inhalers Include Steroids?

MBE em Foco - Volume 8, Issue 10

Crise [de saúde pública] evitada: “é só” tirar os dispositivos eletrônicos e as crianças serão mais fisicamente ativas

EBM Focus - Volume 17, Issue 24

Shortening Long COVID With Vaccines?

EBM Focus - Volume 17, Issue 23

[Public Health] Crisis Averted: ‘Just’ Take Away Devices and Children Will be More Physically Active

EBM Focus - Volume 17, Issue 22

Intermittent Fasting: Metabolic Hack or Mind Trick for Weight Loss?

MBE em Foco - Volume 8, Issue 9

Prevenindo as ITUs de repetição sem antibióticos

EBM Focus - Volume 17, Issue 21

Tirzepatide: Taking STEPS Towards a Promising New Diabetes Treatment

EBM Focus - Volume 17, Issue 20

Don’t Count Allopurinol Out for Gout

MBE em Foco - Volume 8, Issue 8

Campos férteis para a segurança da vacina contra a COVID

EBM Focus - Volume 17, Issue 19

Tracking Fracking for Birth Outcomes

EBM Focus - Volume 17, Issue 18

Fertile Grounds for COVID Vaccine Safety

MBE em foco - Volume 8, Issue 7

Idosos mais saudáveis não se beneficiam da suplementação de vitamina D

EBM Focus - Volume 17, Issue 17

A New ARIA of Alzheimer’s Treatment? Disappointing and Discordant Data for Aducanumab